Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502553 | SCV000593751 | uncertain significance | not specified | 2015-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000812649 | SCV000952969 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-09-24 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985565 | SCV001133863 | uncertain significance | not provided | 2019-08-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000502553 | SCV001361754 | likely benign | not specified | 2020-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367683 | SCV002658593 | likely benign | Hereditary cancer-predisposing syndrome | 2022-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |